首页 | 本学科首页   官方微博 | 高级检索  
     


Update on the Interaction of Rifampin and Warfarin
Authors:Karissa Y. Kim,PharmD,CACP,   Kelly Epplen,PharmD,CACP,   Farzin Foruhari,MD,   Hattie Alexandropoulos,PharmD
Affiliation:From the College of Pharmacy, University of Cincinnati, Cincinnati, OH;;and the Departments of Pharmacy;and Medicine,;St Luke Hospitals Health Alliance, Florence, KY
Abstract:A 79-year-old man with a history of deep vein thrombosis and pulmonary embolism received anticoagulation therapy with warfarin 5 mg daily for 8 months. He was diagnosed with osteomyelitis and underwent partial metatarsal resection of his right foot. After surgery, antibiotics were initiated including ertapenem sodium 1 g intravenously every 24 hours, vancomycin 1400 mg intravenously every 24 hours, and rifampin 300 mg by mouth twice daily. Achieving a therapeutic level of anticoagulation was difficult despite escalating doses of warfarin, because of the interaction with rifampin. A 5- to 6-fold increase in warfarin dose was prescribed to reach therapeutic international normalized ratios (INRs), but even these increases were insufficient to maintain his INR in the therapeutic range. After rifampin was discontinued, warfarin doses were gradually reduced over the next 2 months. When concurrent warfarin-rifampin therapy is necessary, vigilant monitoring is imperative and significant increases in warfarin doses are likely.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号